IHC analysis of tumor infiltrates revealed that combination treatment significantly increased the presence of CD3+ and CD8+ T cells, while not significantly altering the levels of CD4+ T cells or FOXP3+ Tregs (Fig. 4C, see Suppl. The gene discussed is CD4; the disease is neoplasm.